Ivy Natal develops a process to create human egg cells from skin samples as a treatment for most cases of infertility.
Ivy Natal has raised $1.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2022.
Ivy Natal's investors include SOSV, SOSV SF & NY (Fka IndieBio), Alameda Research.
Ivy Natal is headquartered in San Francisco, United States.
Ivy Natal develops a process to create human egg cells from skin samples as a treatment for most cases of infertility.
Ivy Natal is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ivy Natal — Funding & Investors." VCBacked, January 1, 2022, https://www.vcbacked.co/company/ivy-natal. Accessed August 13, 2026.
VCBacked. (2022). Ivy Natal — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/ivy-natal
{{cite web |title=Ivy Natal — Funding & Investors |url=https://www.vcbacked.co/company/ivy-natal |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated